Tier 4 — mechanistic

Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin

Maher P
Genes & Nutrition 2009 4(4):297-307

Bibliography

PubMed
PMID 19756810
PubMed Central
PMC2775892
DOI
10.1007/s12263-009-0142-5
Funding
Supported by the Michael J. Fox Foundation and the Alzheimer's Association.
Competing interests
Not stated in the reviewed sections.

Study snapshot

DesignNarrative review summarising evidence that fisetin maintains neuronal function during ageing via multiple mechanisms: antioxidant activity and glutathione maintenance, mitochondrial ATP preservation, anti-inflammatory (microglial and 5-lipoxygenase) activity, proteasome activity enhancement, and cognitive enhancement (CREB phosphorylation, long-term potentiation, object recognition and Morris water maze performance in young and aged mice).
ModelNot applicable — review; cites HT22 nerve cells, rat primary cortical neurons, rat hippocampal slices, and young/aged mouse behavioural models from the author's and others' primary studies.
SampleNot applicable.
InterventionNot applicable — review of fisetin's neuroprotective and cognition-enhancing mechanisms across cited primary studies (oral doses of 5-500 mg/kg food referenced from cited mouse studies).
DurationNot applicable.
EndpointsNot applicable — narrative synthesis of endpoints reported across cited primary studies (glutathione levels, ATP levels, Nrf2/HO-1 induction, 5-LOX inhibition, proteasome activity, CREB phosphorylation, long-term potentiation, object recognition index, Morris water maze escape latency).

What the study showed, in plain terms

Brain function declines with age through several independent mechanisms — oxidative stress, mitochondrial dysfunction, inflammation, protein-clearance decline, and reduced neurotrophic signalling — and this review by a Salk Institute researcher argues that fisetin is unusual in touching all of them.

The review walks through fisetin's antioxidant and glutathione-boosting effects, its ability to preserve mitochondrial ATP under oxidative stress, its anti-inflammatory action on microglia and 5-lipoxygenase, its modest enhancement of proteasome activity, and its cognitive benefits — including enhanced long-term potentiation and memory in both young and aged mice fed fisetin.

Bottom line: this is the author's own synthesis of a multi-year research programme (not new data in this specific paper), making the case that fisetin's value lies in hitting many small, complementary targets rather than one dominant mechanism — a reasonable rationale for a nutraceutical, but the review predates fisetin's now-prominent senolytic/senotherapeutic literature, which emerged after 2009.

Key findings

The review synthesises evidence that fisetin maintains ageing brain function through several parallel mechanisms: increasing intracellular glutathione and Nrf2 signalling, preserving mitochondrial ATP under oxidative stress, inhibiting 5-lipoxygenase and microglial activation, modestly enhancing proteasome activity, and improving long-term memory in both young and aged mice (via ERK-dependent CREB phosphorylation and hippocampal long-term potentiation), with oral fisetin exhibiting high blood-brain-barrier penetration potential in an in vitro MDR-MDCK model.

What this study can and cannot tell us

This is a single-author narrative review, not new primary data; its conclusions depend on the quality of the underlying cited studies, most of which are rodent or cell-culture work rather than human trials. Published in 2009, it predates fisetin's later senolytic/senotherapeutic research programme and should not be treated as a current synthesis of the field.

Citation network

Articles citing this research paper

2 articles

Biohack Blueprint analyses that reference this study in their evidence base.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology